Stenting for chronic occlusions
This article was originally published in Clinica
Stenting should be the treatment of choice for chronic coronary occlusions, said Dr Per Simes of the Feiring Heart Clinic in Norway. Angioplasty for chronic occlusions carries a high rate of recurrence which has led to most patients being sent for bypass grafting. The data from the Stenting in Chronic Coronary Occlusions (SICCO) trial suggest that stenting can do the job just as well, much less invasively than surgery.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.